Wells Fargo raised the firm’s price target on Cencora (COR) to $274 from $251 and keeps an Equal Weight rating on the shares. The firm is ...

Shares of Cencora Inc. COR slid 2.56% to $254.00 Wednesday, on what proved to be an all-around mixed trading session for the ...

Shares have been on the move with the stock up 6.2% over the past month. The stock hit a new 52-week high of $262.56 in the previous session. Cencora has gained 16.4% since the start of the year ...

We recently published a list of 10 Stocks With At Least $30 Million In Insider Sales Recently. In this article, we are going ...

In early January, the company formerly known as AmerisourceBergen, which owns and operates Besse Medical, purchased Retina ...

We recently published a list of Top 10 Stocks Analysts are Watching as AI Selloff Deepens. In this article, we are going to ...

Fisher Asset Management LLC boosted its stake in shares of Cencora, Inc. (NYSE:COR – Free Report) by 17.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned ...

Major AI stocks are struggling to gain traction as investors rethink their strategies amid concerns of a slowdown in spending ...

Indianapolis-based Eli Lilly and Co. launched LillyDirect a little more than a year ago and has been ramping up efforts to ...

Equities research analysts at Zacks Research decreased their Q2 2025 earnings per share (EPS) estimates for Cencora in a note ...

Shares of Cencora Inc. COR advanced 1.82% to $253.54 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 1.59% to 5,954.50 and ...

Cencora, formerly known as AmerisourceBergen, is one of the Big 3 drug distributors alongside peers McKesson Corporation (MCK) and Cardinal Health, Inc. (CAH). It provides pharmaceutical ...